The global demand for Faecal Calprotectin Testing Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
The faecal calprotectin test is a non-invasive clinical laboratory test that is used to diagnose gastrointestinal problems like inflammatory bowel disease, gastrointestinal infections, celiac disease, and colorectal cancer using a protein biomarker. The enzyme-linked immunoassay (ELISA) approach is used to perform the faecal calprotectin test, which is a quantitative measurement test. The test determines how much inflammation is present in the intestine. As a result, it's inflammation-specific rather than disease-specific. The faecal calprotectin test is primarily utilised as a protein biomarker to differentiate inflammatory bowel illnesses like Crohn's disease and ulcerative colitis from IBS. This test can also be used to predict relapses of inflammatory bowel disease, treatment monitoring, and the prognosis of gastrointestinal disorders.
Market Dynamics
One of the factors likely to drive the global faecal calprotectin test market is the high prevalence and rising incidence rate of inflammatory bowel disease, celiac disease, and colorectal cancer. Furthermore, the calprotectin test is expected to grow in popularity due to its low cost, ease of use, non-invasive nature, and high clinical relevance.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of faecal calprotectin testing. The growth and trends of faecal calprotectin testing industry provide a holistic approach to this study.
Market Segmentation
This section of the faecal calprotectin testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Assay Type
- Elisa (Enzyme Linked Immunosorbent Assay)
- Enzyme Fluoroimmunoassay
- Quantitative Immune-Chromatography
By Application
- Crohn'S Disease
- Ulcerative Colitis
- Colorectal Cancer
By End User
- Hospitals
- Diagnostic Laboratories
- Ambulatory Care Centres
- Research Institutions
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Faecal Calprotectin Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Faecal Calprotectin Testing Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the faecal calprotectin testing market include ALPCO, Alpha Laboratories, bioMérieux SA, Canvax Biotech, DRG Instruments GmbH, Promega Corporation, Svar Lifescience (CALPRO), Arbor Assays, Werfen, BUEHLMANN. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.